Role of Matrix Metalloproteinases in HaCaT Keratinocytes Apoptosis Induced by Loxosceles Venom Sphingomyelinase D  by Paixão-Cavalcante, Danielle et al.
Role of Matrix Metalloproteinases in HaCaT
Keratinocytes Apoptosis Induced by Loxosceles
Venom Sphingomyelinase D
Danielle Paixa˜o-Cavalcante1, Carmen W. van den Berg2, Matheus de Freitas Fernandes-Pedrosa1,
Rute M. Gonc¸alves de Andrade1 and Denise V. Tambourgi1
Envenomation by the spider Loxosceles (brown spider) can result in dermonecrosis and severe ulceration. We
have previously shown that Loxosceles sphingomyelinase D (SMaseD), the enzyme responsible for these
pathological effects, induced expression of matrix metalloproteinase-9 (MMP-9), which is possibly one of the
main factors involved in the pathogenesis of the cutaneous loxoscelism. The aim of this study was to further
investigate the molecular mechanisms triggered by Loxosceles SMaseD involved in the initiation of the
dermonecrotic lesion, using HaCaT cultures, a human keratinocyte cell line, as an in vitro model for cutaneous
loxoscelism. We show here that SMaseD from Loxosceles spider venom induces apoptosis in human
keratinocytes, which is associated with an increased expression of metalloproteinase-2 and -9, and that the use
of metalloproteinase inhibitors, such as tetracycline, may prevent cell death and potentially may prevent tissue
destruction after envenomation.
Journal of Investigative Dermatology (2006) 126, 61–68. doi:10.1038/sj.jid.5700049
INTRODUCTION
Envenomation by spiders of the Loxosceles species (brown
spiders) can produce severe clinical symptoms, including
dermonecrosis, thrombosis, vascular leakage, hemolysis, and
persistent Ramos-cerrille inflammation (Futrell, 1992).
Loxosceles is the most poisonous spider in Brazil and
children who develop the more severe systemic effects after
envenomation nearly always die. At least three different
Loxosceles species of medical importance are known in
Brazil (L. intermedia, L. gaucho, and L. laeta) and more than
3,000 cases of envenomation by L. intermedia alone are
reported each year. In North America, several Loxosceles
species, including L. reclusa (brown recluse), L. apachea,
L. arizonica, L. unicolor, L. deserta, and L. boneti, are known
to be the principal cause of numerous incidents of
envenomation (Ginsburg and Weinberg, 1988; Gendron,
1990; Bey et al., 1997; Ramos-Cerrillo et al., 2004). In South
Africa, L. parrami and L. spinulosa are responsible for
cutaneous loxoscelism (Newlands et al., 1982), and in
Australia, a cosmopolitan species, L. rufescens, is capable
of causing ulceration in humans.
The Loxosceles spider bite, which initially causes only
minor discomfort, can result in chronic ulcer formation and
extensive tissue destruction that may take many months to
heal (Atkins et al., 1958; Wasserman and Anderson,
1983–1984). Local histopathologic alterations in experimen-
tally envenomed animals and in humans bitten by Loxosceles
spiders include increased endothelium thickness and edema,
vasodilatation, vessel wall degeneration, hemorrhage into the
dermis, dermis–epidermis dissociation, and vacuolization of
basal layer keratinocytes (Mackinnon and Witkind, 1953;
Pizzi et al., 1957). The accumulation of polymorphonuclear
leukocytes is associated with the activation of the comple-
ment system (C) (Patel et al., 1994; Tambourgi et al., 2005).
We have purified and cloned several isoforms of
sphingomyelinase D (SMaseD) from L. laeta and L. inter-
media venoms and have shown that they are responsible for
all the local and systemic effects induced by whole venom
(Tambourgi et al., 1998, 2004; Fernandes-Pedrosa et al.,
2002). The venoms of various Loxosceles species contain
several functionally active isoforms of SMaseD, with identity
varying from 40 to 90% (Fernandes Pedrosa et al., 2002;
Ramos-Cerrillo et al., 2004; Tambourgi et al., 2004).
SMaseD from Loxosceles venoms hydrolyze sphingomye-
lin, resulting in the formation of ceramide-1-phosphate
(Cer-1-P or N-acyl-sphingosine-1-phosphate) (Forrester
et al., 1978; Kurpiewski et al., 1981; Tambourgi et al.,
1998) and also catalyze the release of choline from lysopho-
sphatidylcholine in the presence of Mg2þ (van Meeteren
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et al., 2004). Lysophosphatidylcholine is an abundant
phospholipid in plasma, where it is tightly bound to albumin;
removal of its choline headgroup yields lysophosphatidic
acid, a potent lipid mediator with numerous biological
activities in many different cells (Moolenaar, 1999; Chunn
et al., 2002).
We have focused our recent investigations on the effects of
Loxosceles SMaseD on erythrocytes and nucleated cells and
have found that these enzymes induce activation of
membrane-bound metalloproteinases (Tambourgi et al.,
2000; van den Berg et al., 2002). In the case of erythrocytes,
this led to an increased susceptibility to activation of C via the
alternative pathway because of metalloproteinase-induced
cleavage of glycophorins, which are important regulators of C
activation (Tambourgi et al., 2000). However, on nucleated
cells, this led to a decrease in C susceptibility, despite the
cleavage of the C-regulator membrane cofactor protein
(MCP) (van den Berg et al., 2002). On erythrocytes, activation
of the classical pathway of C, possibly by SMaseD-induced
loss of membrane asymmetry (Tambourgi et al., 2002),
resulting in exposure of phosphatidyl serine on the external
lipid monolayer, also contributed to the enzyme-induced
hemolysis. SMaseD-induced exposure of phosphatidyl serine
on the surface of other cells may also explain other
pathological effects observed after envenomation, for exam-
ple, intravascular coagulation; exposure of phosphatidyl
serine on the cell surface of platelets and endothelial cells
is known to initiate the coagulation cascade and initiate
platelet aggregation.
Loss of E membrane asymmetry may be due to the change
of lipid composition induced by the binding and hydrolytic
activity of the spider SMaseD (Rees et al., 1984; Tambourgi
et al., 1995, 1998, 2000, 2002, 2004; Fernandes Pedrosa
et al., 2002). The ability of SMaseD to bind to different
species of erythrocytes (such as humans, sheep, rats, rabbits,
and guinea-pigs) as well as to several cell types (such as
epidermoid cells, hepatocytes, monocytes, B and T cells,
endothelial cells, platelets, and neutrophils) has already been
described (Rees et al., 1984; Tambourgi et al., 1995, 2000;
van den Berg et al., 2002; D.V. Tambourgi, personal
communication). Although no specific receptor has been
described yet for this interaction, the SMaseD binding ability
is certainly an important step for the mechanism of action of
the Loxosceles spider venom.
We have also shown that the C system plays an important
role in the development of cutaneous loxoscelism through the
C5a- and MAC-dependent recruitment of neutrophils (Tam-
bourgi et al., 2005). Furthermore, we have shown that in
rabbits, Loxosceles SMaseD induced the expression of matrix
metalloproteinase-9 (MMP-9), which is possibly one of the
main factors involved in the pathogenesis of the cutaneous
loxoscelism (Tambourgi et al., 2005). The discovery of the
involvement of metalloproteinases in the Loxosceles venom-
induced dermonecrosis is novel and has potential therapeutic
significance given the availability of metalloproteinase
inhibitor drugs. It has been shown that venom from
L. gaucho induced tumor necrosis factor-alpha and venom
from L. deserta induced vascular endothelial growth factor
production by human keratinocytes (Malaque et al., 1999;
Desai et al., 2000), both of which may contribute to the
pathology induced in vivo.
Uncontrolled proteolytic tissue destruction appears to be a
pathogenic factor in nonhealing wounds in which MMPs are
involved. Overexpression of MMPs has been implicated in the
pathogenesis of several diseases, such as tumor progression,
atherosclerotic plaque rupture, aortic aneurisms, acute re-
spiratory distress syndrome, and asthma (Ohnishi et al., 1998).
Tetracycline and chemically modified tetracyclines have been
shown to exert a number of anti-inflammatory and immuno-
modulatory activities, independent of their antibiotic proper-
ties (Kuzin et al., 2001). These include the ability to inhibit
metalloproteinases, a class of enzymes involved in crucial
cellular functions such as remodeling of the extracellular
matrix. Tetracycline can specifically inhibit the expression,
the activation from proenzyme precursor, as well as the
enzymatic activity of metalloproteinases (Hanemaaijer et al.,
1998). Tetracyclines may have considerable potential for
human therapy of MMP-related human diseases (Acharya
et al., 2004).
The aim of this study was to investigate the role of
endogenous MMP in an in vitro model for cutaneous
loxoscelism, using cultured immortalized human keratino-
cytes. Furthermore, we also investigated the ability of
tetracycline and its derivatives, doxycycline and minocy-
cline, to inhibit the clinical symptoms of Loxosceles
envenomation. We used the venom and recombinant
SMaseD of L. intermedia as a model for SMaseD of various
Loxosceles species in this study. Understanding the mole-
cular mechanisms of action of Loxosceles venom will aid in
the development of therapies to alleviate the clinical
symptoms of spider envenomation.
RESULTS
L. intermedia venom and recombinant SMaseD P2 reduce cell
viability
In order to analyze the toxic effects of Loxosceles venom or
its main component, SMaseD, HaCaT cells were incubated
with increasing concentrations of Loxosceles venom or
recombinant SMaseD P2 (rP2) during 3 days and the cell
viability was analyzed by the Alamar Blue method. Figure 1
shows that both venom and the recombinant SMaseD P2
(rP2) were able to induce loss of cell viability; the maximum
percentage of death (60%) was reached at a concentration of
20 mg/ml. The recombinant SMaseD was more efficient in
provoking the loss of cell viability than whole venom. The
data show that SMaseD is a major and possibly unique
enzyme responsible for HaCaT cell death induced by
Loxosceles venom in vitro.
Presence of MMPs in HaCaT cell supernatants
We have recently shown that in rabbits, Loxosceles SMaseD
induces the expression of MMP-9, which is possibly a main
factor involved in the pathogenesis of the cutaneous
loxoscelism (Tambourgi et al., 2005). In order to investigate
the possible association of cell death and MMP expression,
supernatants recovered from HaCaT cells after 3 days of
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treatment with venom or rP2 (15 mg/ml) were analyzed by
gelatin zymography and Western blot. Figure 2a shows an
increased expression/secretion, when compared to non-
treated cells, of a band with a Mr around 68 kDa,
corresponding to the active form of MMP-2, and a band
with Mr around 90 kDa, corresponding to the active form of
MMP-9 in the supernatants of cells treated with venom or
rP2. A band around 72 kDa, corresponding to the proform of
MMP-2, with the same intensity, was observed in treated and
nontreated samples. The increased expression of MMP-2 and
-9 in the supernatants of human HaCaT cells, treated with
venom or rP2, was confirmed by Western blot using specific
monoclonal antibodies (MoAbs) (Figure 2b and c) and ELISA
(data not shown).
In order to evaluate if inhibitors of metalloproteinases
could modulate the expression of these gelatinases, cells
were incubated with medium, venom, or rP2 in the presence
or absence of tetracycline (50 mg/ml) and analyzed by
Western blot. Figure 2b and c shows that tetracycline largely
prevented secretion of MMP-2 and -9 by HaCaT cells.
Inhibition of HaCaT cell death
In order to further investigate the possible association of loss
of cell viability and MMPs expression, HaCaT cells were
treated with Loxosceles venom or rP2 (15 mg/ml) in the
presence of increasing concentrations of tetracycline, doxy-
cycline, or minocycline. Figure 3 shows that tetracycline at a
concentration of 40 mg/ml could fully protect HaCaT cells
from cell death induced by Loxosceles venom (Figure 3a).
Doxycycline and minocycline were less effective in protect-
ing cells from death induced by venom. The maximum
protection, against the toxic effects of rP2, achieved by using
tetracycline, doxycycline, or minocycline was 90% (Figure
3b). The tetracyclines, in the doses used, did not affect HaCaT
cell viability (data not shown).
Binding of SMaseD to HaCaT
The protection against the toxic effects of SMaseD from
Loxosceles venom obtained with the use of tetracycline in
keratinocyte cultures could be due to the interaction of this
inhibitor with the enzyme, thus reducing their ability to bind
and act on the cell surface. In order to evaluate this
possibility, HaCaT cells were treated with 15 mg/ml of venom
or rP2 (2 hours at 371C) in the presence of tetracycline (50 mg/
ml). Cultures incubated with EDTA (10 mM) were also used as
control, since we have previously shown that this agent could
prevent SMaseD action and binding to cells, as the toxin is
dependent on Mg2þ for membrane association and lipase
activity (Tambourgi et al., 1998, 2000; van Meeteren et al.,
2004; Murakami et al., 2005). Binding of SMaseD to the cell
surface was analyzed by flow cytometry using a specific
antibody (anti-F35). Figure 4a shows that the association of
SMases to the cell surface was impaired by the use of EDTA,
but not by tetracycline. These results indicate that tetra-
cycline, in the concentration used, did not interfere with the
association of the toxins with the cell membrane.
Venom and rP2 effect on cell surface markers
We have previously shown that endogenous membrane-
bound metalloproteinases activated by Loxosceles venom are
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Figure 1. Effect of L. intermedia venom and rP2 treatment on human
keratinocytes cell viability. HaCaT cell cultures (1 105 cells/ml) were
incubated with increasing concentrations of Loxosceles venom (K) or rP2
(J), and after 3 days of treatment, cell viability was analyzed by the Alamar
Blue assay. Results are representative of two independent experiments and are
expressed as the mean of triplicates 7standard deviation. The asterisks
indicate values statistically different (Po0.05) from the control.
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Figure 2. Loxosceles venom SMaseD induces the expression of gelatinases in
HaCaT cell line. Zymography analysis of HaCaT cell culture supernatants
after 3 days of treatment with medium (C), 15 mg/ml of venom (V), or rP2 (a).
The supernatants of HaCaT cell cultures treated with 15 mg/ml of venom (V) or
rP2 or medium (C), in the presence or absence of tetracycline (50 mg/ml) for 3
days, were run on 12.5% SDS-PAGE gel under nonreducing conditions and
Western blotted using MoAbs against human MMP-2 (b) or anti-MMP-9 (c).
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Figure 3. Effect of tetracycline, doxycycline, and minocycline on loss of cell
viability of human keratinocytes induced by L. intermedia venom or rP2.
HaCaT cells (1 105 cells/ml) were cultivated in 24-well plates in DMEM
without FBS. At day 0, cells were treated with 15mg/ml of venom (a) or rP2
(b) and simultaneously incubated with different concentrations of tetracycline
(m), doxycycline (n), or minocycline (J). Three days of treatment, the cell
viability was analyzed by the Alamar Blue assay. Results are representative of
two independent experiments and are expressed as the mean of triplicates
7standard deviation. The asterisks indicate values statistically different
(Po0.05) from the control.
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responsible for the release of some cell surface proteins such
as MCP, major histocompatibility complex I, and b2-micro-
globulin on human endothelial cells (van den Berg et al.,
2002). We have also tested if venom and the recombinant
SMaseD from L. intermedia spider could interfere with
the expression of these membrane-bound cell surface
molecules on HaCaT cells. By flow cytometry cell surface
analysis, a reduction in the expression of MCP and b2-
microglobulin was detected after a 2-hour incubation of
HaCaT with 15 mg/ml of Loxosceles venom or rP2 (Figure 4b
and c). The EGF receptor (EGFR) plays an important role in
wound healing. We show here that EGFR is also removed
from the cell surface after incubation of the HaCaT cells with
Loxosceles venom or rP2 (Figure 4d). Cleavage of all these
cell surface molecules could be prevented by EDTA (10 mM),
but not by tetracycline (50 mg/ml) (Figure 4b–d).
Binding of Annexin V and propidum iodide
Detection of a reduction in the expression of EGFR caused by
Loxosceles venom/SMaseD stimulus is novel and has
important implications since it has been reported that
reduction of the expression of this receptor is associated
with the induction of apoptosis (Shao et al., 2003). In order to
investigate if the removal of EGFR was associated with
HaCaT cell death via apoptosis, cells incubated with venom
or rP2 (15 mg/ml) were analyzed by flow cytometry, after
staining with Annexin-FITC and propidium iodide (PI), or by
DNA fragmentation. A significant increase in Annexin V-FITC
and PI binding on the HaCaT cell surface (typical of late
apoptosis) was observed after 24 hours of venom or rP2
treatment, as compared to control cells, incubated with
Dalbecco’s modified Eagle’s medium (DMEM) (Figure 5). The
exposure of phosphatidylserine on the outside of the cell
membrane was more evident after rP2 treatment.
Induction of apoptosis was confirmed by DNA gel
electrophoresis. DNA fragmentation was observed in samples
obtained from cells treated with venom or rP2 (Figure 6). The
same pattern of degradation was observed after incubation
with hydrogen peroxide, a well-known inducer of apoptosis
(Cardoso et al., 2004). Tetracycline prevented apoptosis in
cells treated with venom rP2, but not with hydrogen peroxide
(Figure 6).
DISCUSSION
Envenomation by Loxosceles spiders is a well-documented
cause of necrotic skin lesions in humans. SMaseD is the
primary enzyme in Loxosceles venom responsible for their
major clinical effects in humans.
We have previously shown that SMaseD induces in rabbit
skin the expression of MMP-9, which was associated with the
pathogenesis of the cutaneous loxoscelism (Tambourgi et al.,
2005). The mammalian MMPs (also known as matrixins)
belong to a family of zinc-dependent neutral secreted or
surface-bound endopeptidases, which are involved in the
degradation of the extracellular matrix, an important feature
in many normal and abnormal biological conditions. MMPs
have been identified to have a role in various physiological
conditions such as fetal tissue development and postnatal
tissue repair, and certain pathological conditions like perio-
dontitis, autoimmune disorders of skin and dermal photo-
aging, rheumatoid arthritis, osteoarthritis, chronic ulcerations,
uterine involution, wound healing, bone resorption, and
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Figure 4. Effect of L. intermedia venom and SMaseD on the expression of keratinocyte cell surface antigens. HaCaT cells (107 cells/ml) were treated with
buffer (C), Loxosceles venom (V), or rP2 (15 mg/ml) for 2 hours at 371C in the presence or absence of tetracycline (50mg/ml) or EDTA (10 mM). Binding
of the SMaseD (a), using anti-F35 polyclonal antibody, and expression of MCP (b), b2-microglobulin (c), and EGFR (d), using specific MoAbs, were analyzed
by flow cytometry. Results are representative of three different experiments expressed as the mean of duplicates7standard deviation.
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tumor progression and metastasis. Their activity can be
regulated at four levels: induction of MMP genes, vesicle
trafficking and secretion, activation of latent proforms, and
complexing with specific tissue inhibitors of metalloprotei-
nases (Acharya et al., 2004).
Data we present here show that venom and the
recombinant SMaseD P2 from L. intermedia spider induce
an increased expression/secretion of MMP-2 and -9 in the
keratinocytic cell line HaCaT. The augmentation of MMPs
expression/secretion coincided with the reduction of cell
viability, which occurred by apoptosis, since loss of
membrane asymmetry and DNA degradation were detected
in these cells.
Several agents have been developed to block the synthesis
of MMPs, prevent them from interacting with the molecules
that direct their activities to the cell surface, or inhibit their
enzymatic activity (Blavier et al., 1999; Egeblad and Werb,
2002). Inhibitors of MMPs can be broadly classified as being
nonsynthetic (eg endogenous tissue inhibitors of metallopro-
teinases) or synthetic (eg collagen peptidomimetics, non-
peptidomimetics, bisphosphonates, tetracycline derivatives).
The tetracycline derivatives inhibit not only the activity but
also the production of MMPs and are thus being investigated
for the treatment of disorders in which the MMP system is
amplified (Golub et al., 1998; Greenwald et al., 1998). This
family of agents comprises both the classic tetracycline
antibiotics, such as tetracycline, doxycycline, and mino-
cycline, and the newer tetracycline analogs that have been
chemically modified to eliminate their antimicrobial activity.
These agents inhibit the collagenases, MMP-1, -3, and -13, and
the gelatinases, MMP-2 and -9, via multiple mechanisms
(Ryan et al., 1996; Golub et al., 1998), including blocking the
activity of mature MMPs by chelation of the zinc atom at the
enzyme binding site, interfering with the proteolytic activation
of pro-MMP into their active form, and reducing the expression
of MMPs and protecting MMPs from proteolytic and oxidative
degradation. Some tetracycline derivatives have been evalu-
ated in preclinical cancer models and have entered early
clinical trials in patients with malignant diseases.
In our experimental model, the classic tetracycline
antibiotics (tetracycline, doxycycline, and minocycline)
modulated the toxic action of L. intermedia venom SMaseD
on HaCaT cells, inhibiting not only the increased expression/
secretion of MMP-2 and -9 but also the DNA degradation and
binding of Annexin V, thus protecting cells from loss of cell
viability.
Loxosceles venom and SMaseD also induced a significant
reduction in the expression of MCP, b2-microglobulin, and
EGFR; however, tetracycline was unable to prevent the
release of these proteins from the keratinocyte cell surface.
We have previously shown that MCP was released into the
supernatant as a truncated form from endothelial cell
cultures, by activation of a metalloproteinase. This event
could be inhibited by 1,10 phenanthroline, but not by
phenylmethanesulfonyl fluoride or by the MMP-specific
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Figure 5. Binding of Annexin V and PI to HaCaT treated with L. intermedia venom and rP2. HaCaT cell cultures, in DMEM without FBS, were treated with
15mg/ml of venom or rP2 for 24 hours at 371C. As control, the cells were incubated with buffer. After incubation, cells were detached, washed in cold PBS, and
incubated with Annexin V-FITC and PI as recommended by the manufacturer (R&D Systems Inc.) and analyzed by flow cytometry.
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Figure 6. DNA gel eletrophoresis. HaCaT cells, cultured in DMEM without
FBS, were treated with 15 mg/ml of venom (V) or rP2 for 24 hours at 371C in
the presence (þ ) or absence of tetracycline (50 mg/ml). Cells incubated with
PBS (C) and hydrogen peroxide (H2O2) (100mM) were used as negative and
positive controls, respectively. After incubation, cells were detached, washed
in cold PBS, and the DNA was isolated using Trizol reagent and analyzed by
agarose gel electrophoresis.
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metalloproteinase inhibitor, tissue inhibitors of metallopro-
teinase-2, suggesting that MMPs were not involved and that
the metalloproteinase activated on cell surface was a member
of adamalysins (van den Berg et al., 2002). Taken together,
these data indicate that two groups of metalloproteinases are
induced/activated by Loxosceles, i.e., secreted MMPs which
expression/secretion can be controlled by tetracyclines, and a
membrane-associated metalloproteinase, possibly from the
adamalysin family.
Our observation that Loxosceles venom SMaseD also
causes reduction in the expression of EGFR on the HaCaT cell
surface is remarkable since EGFR signaling can be modulated
during inflammatory processes, thereby affecting cell pro-
liferation and thus having implications in wound repair.
EGFR is a transmembrane protein with intrinsic tyrosine
kinase activity, which transduces important signals from the
surface of epithelial cells to the intracellular domain. In scar
formation, EGFR expression is greater that in normal skin. The
overexpression of EGFR contributes to the migration of cells
from the ulcer margin and formation of granulation tissue and
microvessels (angiogenesis) during the ulcer healing process
(Cheng et al., 2002; Gibson, 2004; McGaffin et al., 2004;
Satish et al., 2004). The difficult healing observed in the
lesions induced by Loxosceles venom may be attributed to
the decrease in EGFR expression.
In conclusion, we have demonstrated that SMaseD from
L. intermedia venom provokes apoptosis in the HaCaT
immortalized keratinocyte cell line by an indirect process that
involves an augmented expression and secretion of MMP-2 and
-9. The discovery of the ability of metalloproteinase inhibitor
drugs, such as tetracyclines, to control the noxious effects of
Loxosceles venom associated with the dermonecrotic process
is novel and of potential therapeutic significance. The use of
this inhibitor in experimental in vivo models of cutaneous
loxoscelism is the subject of further study.
MATERIALS AND METHODS
Chemicals, reagents, and buffers
Tween 20, BSA, paraformaldehyde, gelatin, Triton X-100, tetra-
cycline, doxycycline, minocycline, and EDTA were purchased from
Sigma (St Louis, MO). 5-Bromo-4-chloro-3-indolyl-phosphate and
nitroblue tetrazolium were from Promega Corp. (Madison, WI).
Annexin V-FITC and PI were from R&D Systems Inc. (Minneapolis,
MN). Trizol reagent was from Invitrogen Inc. (Burlington, Canada).
Buffers were veronal-buffered saline, pH 7.4 (10 mM Na barbitone,
0.15 mM CaCl2, and 0.5 mM MgCl2), PBS, pH 7.2, 10 mM Na
phosphate, 150 mM NaCl, and FACS buffer (PBS, 1% BSA, and
0.01% sodium azide).
Antibodies
MoAbs against EGFR (Ab-10/111:16) were from Novacastra Labs
(New Castle, UK) and those against human MMP-2 and -9 were from
R&D Systems (Minneapolis, MN). MoAb against MCP (GB24) was
kindly donated by Dr John Atkinson (St Louis, MO) and that against
b2-microglobulin (b2-m/01) by Dr Vaclav Horejsi (Prague, Czech
Republic). Rabbit polyclonal antibody against F35 (fraction contain-
ing SMaseD isoforms from L. intermedia venom) was made in-house
(Tambourgi et al., 1995). Rabbit anti-mouse IgG-FITC (RAM-FITC)
and goat anti-rabbit IgG-FITC (GAR-FITC) were from Amersham
Pharmacia Biotech (Buckinghamshire, UK). Goat anti-mouse IgG-
alkaline phosphatase (GAM-IgG-AP) was from Promega Corp.
Venom
L. intermedia spiders were provided by ‘‘Laborato´rio de Imunoquı´-
mica, Instituto Butantan, SP, Brazil’’. The venom was obtained by
electrostimulation by the method of Bucherl (1969), with slight
modifications. Briefly, electric stimuli of 15–20 V were repeatedly
applied to the spider sternum and the venom drops were collected
with a micropipette, vacuum–dried, and stored at 20oC. Stock
solutions were prepared in PBS at 1.0 mg/ml.
SMase expression
Recombinant L. intermedia SMaseD named as P2 (accession number
AY304472) was expressed in E. coli strain BL21 (DE3) as a fusion
protein composed of the mature SMaseD with an N-terminal
extension containing a 6 histidine tag and was purified as
described (Tambourgi et al., 2004). rP2 was purified from the
soluble fraction of cell lysates on an Ni (II) chelating sepharose fast
flow column (Pharmacia). Recombinant proteins were eluted with
the elution buffer (100 mM Tris-HCl, pH 8.0; 300 mM NaCl; 0.8 M
imidazole) and dialyzed against PBS. The protein content of the
samples was evaluated by the Lowry method (Lowry et al., 1951).
Cell culture and maintenance
The human keratinocyte cell line, HaCaT, kindly donated by Dr
Fusening (Heidelberg, Germany), was maintained in DMEM (Gibco-
BRL, Gaithersburg, MD), supplemented with 10% (vol/vol) heat-
inactivated (561C, 30 minutes) fetal bovine serum (FBS; Gibco-BRL),
100 IU/ml penicillin, and 100 IU/ml streptomycin at 371C in
humidified air with 5% CO2. Institutional approval was not required
since experiments were performed in vitro using immortalized cells.
Viability assay
The cell viability was analyzed by Alamar Blue assay (Nakayama
et al., 1997). Briefly, HaCaT cells were subcultured in 24-well plates
in DMEM plus FBS at 1 105 cells/ml (0.5 ml/well). One day before
starting the treatment, the cells were maintained overnight in DMEM
without FBS, followed by incubation with different concentrations of
venom or rP2 in the presence or absence of increasing amounts of the
different metalloproteinases inhibitors, for example, tetracycline,
minocycline, doxycycline, or EDTA diluted in DMEM without FBS.
DMEM without FBS was used as the control. After 3 days of
incubation, the culture supernatants were collected and the cells were
incubated with 250ml/well of DMEM plus 10% of Alamar Blue
reagent (Biosource International, Camarillo, CA) for 1 hour at 371C.
Alamar Blue added to wells not containing cells was used as the
background control. Supernatants of each sample (100ml) were
collected and mixed with 100ml of water and the absorbance was
measured in a spectrophotometer (Multiskan-EX, Labsystems, Finland)
at 540 and 620 nm. The relative cell viability was calculated as
½ðsample ODð5402620 nmÞ  background control ODð5402620 nmÞÞ/
ðcontrol ODð5402620 nmÞ  background ODð540620 nmÞÞ100:
The Student’s t-test was used to determine the significance of the
differences between the mean values of cell viability from control
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and experimental samples. The minimal level of significance was
considered as Po0.05.
Flow cytometry
Analyses of the expression of cell surface antigens and binding of
venom SMaseD to the keratinocytes were assessed by flow
cytometry. HaCaT cells were harvested and incubated at 1 107
cells/ml in veronal-buffered saline with L. intermedia venom or rP2
(15 mg/ml, for 2 hours at 371C) in the presence or absence of
tetracycline (50 mg/ml) or EDTA (10 mM). Cells were washed and
resuspended in FACS buffer at 3 106 cells/ml. Fifty microliters of
cells were incubated with 50 ml of MoAbs against MCP, b2m, or
EGFR or with polyclonal serum against F35 (between 1 and 10mg/
ml) and incubated for 30 minutes at 41C. The cells were washed
three times and incubated with FITC-labeled secondary antibodies
for 30 minutes at 41C. The cells were washed and fixed in FACS
buffer containing 1% paraformaldehyde and analyzed by flow
cytometry (FACScalibur, Becton Dickinson, CA). Analysis of
Annexin V-FITC and PI cell staining was carried out after 24 hours
of incubation of HaCaT cell cultures, in DMEM without FBS at 371C
in humidified air with 5% CO2, with venom or rP2 (15 mg/ml). After
incubation, cells were detached, washed in cold PBS, and incubated
with Annexin V-FITC and PI as recommended by the manufacturer
(R&D Systems Inc.). Cells incubated with DMEM were used as
negative control.
Analysis of DNA fragmentation
HaCaT cells were treated with venom or rP2 (15 mg/ml) for 24 hours
and DNA was isolated using Trizol reagent (Invitrogen Inc.)
according to the manufacturer’s instructions. After 5 minutes of
incubation, chloroform was added and the samples were centrifuged
at 12,000 r.p.m. for 15 minutes at 41C. The interface, containing
DNA, was collected and the DNA precipitated, washed, and
solubilized in water and analyzed by agarose gel electrophoresis.
As positive and negative controls, DNA samples were obtained from
cells treated with 100 mM of hydrogen peroxide or medium,
respectively. Samples of DNA (10 mg/well) were loaded on a 1%
agarose gel containing 1mg/ml of ethidium bromide. The electro-
phoresis was performed for 1 hour at 90 V and the DNA was
visualized by UV fluorescence.
Gelatin zymography
Gelatinase activity was analyzed by zymography as described
(Kleiner and Stetler-Stwenson, 1994). Supernatants from HaCaT
cells, collected after 3 days of incubation with venom or rP2 (15mg/
ml), were analyzed by gelatin zymography. Supernatants of cells
incubated with DMEM were used as negative control. The super-
natants were mixed with SDS-PAGE sample buffer and run on a 10%
polyacrylamide gel containing 0.1% gelatin. The gels were washed
twice for 30 minutes at room temperature in 2.5% Triton X-100, and
incubated overnight at 371C in zymography buffer (50 mM Tris-HCl,
200 mM NaCl, 10 mM CaCl2, 0.05% Brij-35; pH 8.3). Gels were
stained in Coomassie brilliant blue solution (40% methanol, 10%
acetic acid, and 0.1% Coomassie brilliant blue).
Electrophoresis and Western blotting
Supernatants of HaCaT cells incubated with DMEM, venom, or rP2
(15 mg/ml), in the presence or absence of tetracycline (50 mg/ml),
were run on 12.5% SDS-PAGE under nonreducing conditions. Gels
were blotted onto nitrocellulose and the membranes were blocked
with PBS/5% BSA and incubated with mAb against human MMP-9
and anti-MMP-2 (10 mg/ml) for 1 hour at 371C. Membranes were
washed three times with PBS/0.05% Tween 20 for 5 minutes and
then incubated with GAM-IgG-AP (1/5,000) in PBS/5% BSA for
1 hour at 371C. After washing three times with PBS/0.05% Tween 20
for 10 minutes, blots were developed using nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl-phosphate according to the manufac-
turer’s instructions (Promega).
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